Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com
by Kim Johansen · The Markets DailyStockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Friday morning. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $2.47. The stock has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.02. The firm has a market cap of $2,951.00, a P/E ratio of 0.00 and a beta of 3.71.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Stories
- Five stocks we like better than Ampio Pharmaceuticals
- Market Cap Calculator: How to Calculate Market Cap
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Most Volatile Stocks, What Investors Need to Know
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- The Most Important Warren Buffett Stock for Investors: His Own
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year